Wayfair shareholders approve 20M share increase for 2023 Incentive Award Plan

Wayfair Inc.

Shareholders approved Amendment No. 1 to add 20,000,000 shares to the 2023 Incentive Award Plan.
All nine director nominees elected, including co-founders Niraj Shah and Steven Conine.
Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026.
Advisory vote on executive compensation passed with 247.8M for, 60.9M against.
Plan amendment vote: 253.7M for, 54.9M against, 19.3K abstain (excluding broker non-votes).

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001616707-26-000122
form_type: 8-K
ticker: W
cik: 0001616707
company_name: Wayfair Inc.
filed_at: 2026-05-22T10:46:38+00:00
discovered_at: 2026-05-22T10:50:00.289249+00:00
generated_at: 2026-05-22T10:50:18.007264+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001616707-26-000122
json_url: https://secwatch.observer/filing/0001616707-26-000122.json
markdown_url: https://secwatch.observer/filing/0001616707-26-000122.md
text_url: https://secwatch.observer/filing/0001616707-26-000122.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1616707/000161670726000122/0001616707-26-000122-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1616707/000161670726000122/w-20260521.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

EDSA

Edesa Biotech shareholders approve equity plan amendment adding 750K shares

Edesa Biotech, Inc. May 29, 2026, 4:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

ONDS

Ondas shareholders approve increase in authorized shares to 1.2B and stock plan pool to 81M shares

Ondas Inc. May 28, 2026, 4:09 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

HAFC

Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP

HANMI FINANCIAL CORP May 27, 2026, 6:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

RLMD

Relmada increases authorized common shares to 200M; stockholders approve 2021 Plan amendment

RELMADA THERAPEUTICS, INC. May 28, 2026, 4:59 PM ET other Items 5.03, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

NBIX

Neurocrine annual meeting re-elects three directors, approves equity plan and auditor

NEUROCRINE BIOSCIENCES INC May 28, 2026, 4:01 PM ET other Items 5.02, 5.07

same SEC item: 5.02, 5.07 same event type: other similar materiality

Filing page SEC filing

NEXM

NexMetals shareholders elect eight directors, approve auditor and equity plan at AGM

NexMetals Mining Corp. May 28, 2026, 3:23 PM ET other Items 5.07, 7.01, 9.01

same SEC item: 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

PAL

Proficient Auto Logistics to attend William Blair conference; sets Q2 2026 earnings call for Aug 10

Proficient Auto Logistics, Inc June 1, 2026, 5:29 PM ET other Items 7.01, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

REVB

Revelation Biosciences releases updated corporate presentation without disclosed details

REVELATION BIOSCIENCES, INC. June 1, 2026, 5:26 PM ET other Items 8.01, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001616707-26-000122

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.